127 related articles for article (PubMed ID: 31691051)
1. Structure elaboration of isoniazid: synthesis, in silico molecular docking and antimycobacterial activity of isoniazid-pyrimidine conjugates.
Kaur H; Singh L; Chibale K; Singh K
Mol Divers; 2020 Nov; 24(4):949-955. PubMed ID: 31691051
[TBL] [Abstract][Full Text] [Related]
2. Transferrin conjugates of antitubercular drug isoniazid: Synthesis and in vitro efficacy.
Sutar YB; Mali JK; Telvekar VN; Rajmani RS; Singh A
Eur J Med Chem; 2019 Dec; 183():111713. PubMed ID: 31557610
[TBL] [Abstract][Full Text] [Related]
3. Structure-based design, synthesis and biological evaluation of a newer series of pyrazolo[1,5-a]pyrimidine analogues as potential anti-tubercular agents.
Modi P; Patel S; Chhabria M
Bioorg Chem; 2019 Jun; 87():240-251. PubMed ID: 30908967
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of novel 1,2,3-triazole derivatives of isoniazid and their in vitro and in vivo antimycobacterial activity evaluation.
Kumar D; Beena ; Khare G; Kidwai S; Tyagi AK; Singh R; Rawat DS
Eur J Med Chem; 2014 Jun; 81():301-13. PubMed ID: 24852277
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, and structure-activity relationship for C(4) and/or C(5) thienyl substituted pyrimidines, as a new family of antimycobacterial compounds.
Verbitskiy EV; Cheprakova EM; Slepukhin PA; Kravchenko MA; Skornyakov SN; Rusinov GL; Chupakhin ON; Charushin VN
Eur J Med Chem; 2015 Jun; 97():225-34. PubMed ID: 25982331
[TBL] [Abstract][Full Text] [Related]
6. New INH-pyrazole analogs: Design, synthesis and evaluation of antitubercular and antibacterial activity.
Nayak N; Ramprasad J; Dalimba U
Bioorg Med Chem Lett; 2015 Dec; 25(23):5540-5. PubMed ID: 26520663
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological evaluation of 1H-pyrrolo[2,3-d]pyrimidine-1,2,3-triazole derivatives as novel anti-tubercular agents.
Shiva Raju K; AnkiReddy S; Sabitha G; Siva Krishna V; Sriram D; Bharathi Reddy K; Rao Sagurthi S
Bioorg Med Chem Lett; 2019 Jan; 29(2):284-290. PubMed ID: 30497913
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, and antimycobacterial property of PEG-bis(INH) conjugates.
Kakkar D; Tiwari AK; Chuttani K; Khanna A; Datta A; Singh H; Mishra AK
Chem Biol Drug Des; 2012 Aug; 80(2):245-53. PubMed ID: 22515497
[TBL] [Abstract][Full Text] [Related]
9. A structure-based strategy toward the development of novel candidates for antimycobacterial activity: Synthesis, biological evaluation, and docking study.
Li L; Jin Y; Wang B; Yang Z; Liu M; Guo H; Zhang J; Lu Y
Chem Biol Drug Des; 2018 Mar; 91(3):769-780. PubMed ID: 29130630
[TBL] [Abstract][Full Text] [Related]
10. Design and synthesis of 4-Aminoquinoline-isoindoline-dione-isoniazid triads as potential anti-mycobacterials.
Rani A; Johansen MD; Roquet-Banères F; Kremer L; Awolade P; Ebenezer O; Singh P; Sumanjit ; Kumar V
Bioorg Med Chem Lett; 2020 Nov; 30(22):127576. PubMed ID: 32980514
[TBL] [Abstract][Full Text] [Related]
11. Microwave-assisted synthesis, molecular docking and antitubercular activity of 1,2,3,4-tetrahydropyrimidine-5-carbonitrile derivatives.
Mohan SB; Ravi Kumar BV; Dinda SC; Naik D; Prabu Seenivasan S; Kumar V; Rana DN; Brahmkshatriya PS
Bioorg Med Chem Lett; 2012 Dec; 22(24):7539-42. PubMed ID: 23122523
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and in vitro evaluation of substituted pyrimido[5,4-d]pyrimidines as a novel class of anti-Mycobacterium tuberculosis agents.
Bacelar AH; Carvalho MA; Proença MF
Eur J Med Chem; 2010 Jul; 45(7):3234-9. PubMed ID: 20416983
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and antimycobacterial activity of isoniazid derivatives from renewable fatty acids.
Rodrigues MO; Cantos JB; D'Oca CR; Soares KL; Coelho TS; Piovesan LA; Russowsky D; da Silva PA; D'Oca MG
Bioorg Med Chem; 2013 Nov; 21(22):6910-4. PubMed ID: 24103427
[TBL] [Abstract][Full Text] [Related]
14. Mode of binding of the tuberculosis prodrug isoniazid to heme peroxidases: binding studies and crystal structure of bovine lactoperoxidase with isoniazid at 2.7 A resolution.
Singh AK; Kumar RP; Pandey N; Singh N; Sinha M; Bhushan A; Kaur P; Sharma S; Singh TP
J Biol Chem; 2010 Jan; 285(2):1569-76. PubMed ID: 19907057
[TBL] [Abstract][Full Text] [Related]
15. The Introduction of Hydrazone, Hydrazide, or Azepane Moieties to the Triterpenoid Core Enhances an Activity Against
Kazakova OB; Medvedeva NI; Smirnova IE; Lopatina TV; Veselovsky AV
Med Chem; 2021; 17(2):134-145. PubMed ID: 31939731
[TBL] [Abstract][Full Text] [Related]
16. Mutation of katG in a clinical isolate of Mycobacterium tuberculosis: effects on catalase-peroxidase for isoniazid activation.
Purkan ; Ihsanawati ; Natalia D; Syah YM; Retnoningrum DS; Kusuma HS
Ukr Biochem J; 2016; 88(5):71-81. PubMed ID: 29235814
[TBL] [Abstract][Full Text] [Related]
17. Analysis of interactions of clinical mutants of catalase-peroxidase (KatG) responsible for isoniazid resistance in Mycobacterium tuberculosis with derivatives of isoniazid.
Unissa AN; Doss C GP; Kumar T; Swathi S; Lakshmi AR; Hanna LE
J Glob Antimicrob Resist; 2017 Dec; 11():57-67. PubMed ID: 28743650
[TBL] [Abstract][Full Text] [Related]
18. Anti-tubercular profile of new selenium-menadione conjugates against Mycobacterium tuberculosis H37Rv (ATCC 27294) strain and multidrug-resistant clinical isolates.
Ribeiro RCB; de Marins DB; Di Leo I; da Silva Gomes L; de Moraes MG; Abbadi BL; Villela AD; da Silva WF; da Silva LCRP; Machado P; Bizarro CV; Basso LA; Cristina de Moraes M; Ferreira VF; da Silva FC; Nascimento V
Eur J Med Chem; 2021 Jan; 209():112859. PubMed ID: 33010635
[TBL] [Abstract][Full Text] [Related]
19. Reversed isoniazids: Design, synthesis and evaluation against Mycobacterium tuberculosis.
Kumar M; Singh K; Ngwane AH; Hamzabegovic F; Abate G; Baker B; Wiid I; Hoft DF; Ruminski P; Chibale K
Bioorg Med Chem; 2018 Feb; 26(4):833-844. PubMed ID: 29373270
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis and antimycobacterial activity of benzoxazinone derivatives and open-ring analogues: Preliminary data and computational analysis.
Zampieri D; Mamolo MG; Filingeri J; Fortuna S; De Logu A; Sanna A; Zanon D
Bioorg Med Chem Lett; 2019 Sep; 29(17):2468-2474. PubMed ID: 31350124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
